Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cbf41a0bc642c2861b0328fa4909fd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_515a544de365df93fb8b28a1a08bde0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faa8214148b9b105d1eb2111a7a40a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc9b6f8cd54cebbbe1acc7d1774d710b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-38 |
filingDate |
2008-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c848d7ec4ce968125bef8687db2fd24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ee7141569863c2a9ba7a8d04ca986f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c6bc5925a314975e160b4c8455d5ffb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab2f0abbcd9c63261f40defd2e3201a |
publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009059281-A1 |
titleOfInvention |
Compositions and methods for using ca9 protein to stimulate an immune response |
abstract |
Provided are methods for stimulating an immune response to an antigen by administering a composition to an individual in an amount effective to stimulate an immune response to the antigen. The stimulated immune response to the antigen is greater than the immune response stimulated by the antigen in the absence of CA9 protein. The compositions provided contain a complex that includes an antigen and an isolated CA9 protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011177129-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050291-B2 |
priorityDate |
2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |